Drug Trial Radar · NCT01881763
Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression
Last checked: Nov 20, 2026Latest source record: Mar 9, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
31
Actual
Start
Jun 2010
Primary completion
Mar 2017
Study completion Jul 2017
Sponsor
- Lead sponsor
- Northwell HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Alliance for Research on Schizophrenia and Depression
- First posted
- Jun 20, 2013
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study aims to compare outcomes of Electroconvulsive Therapy (ECT) using ketamine versus methohexital anesthesia in depressed patients. The investigators hypothesize that patients who receive ketamine anesthesia during ECT will achieve remission status faster than those receiving methohexital anesthesia. Also, at the end of the ECT course subjects will display fewer cognitive side effects compared to those treated with methohexital anesthesia.
Conditions
- Unipolar Depression
- Bipolar Depression
Interventions
KetamineDrug
Ketamine 1-2 mgr/ kg IV
MethohexitalDrug
Methohexital 0.5-1mg/kg IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hamilton Rating Scale for Depression (HRSD) ImprovementTime frame: Days required to achieve remission (on average 3-4 weeks)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Zucker Hillside Hospital
Glen Oaks, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.